ADITXT INC (ADTX) Fundamental Analysis & Valuation

NASDAQ:ADTX • US0070258779

Current stock price

0.502 USD
-0.03 (-5.28%)
At close:
0.5015 USD
0 (-0.1%)
After Hours:

This ADTX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ADTX Profitability Analysis

1.1 Basic Checks

  • In the past year ADTX has reported negative net income.
  • In the past year ADTX has reported a negative cash flow from operations.
  • In the past 5 years ADTX always reported negative net income.
  • In the past 5 years ADTX always reported negative operating cash flow.
ADTX Yearly Net Income VS EBIT VS OCF VS FCFADTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • ADTX has a worse Return On Assets (-357.97%) than 93.04% of its industry peers.
Industry RankSector Rank
ROA -357.97%
ROE N/A
ROIC N/A
ROA(3y)-152.11%
ROA(5y)-160.9%
ROE(3y)-396.44%
ROE(5y)-345.59%
ROIC(3y)N/A
ROIC(5y)N/A
ADTX Yearly ROA, ROE, ROICADTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

  • ADTX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADTX Yearly Profit, Operating, Gross MarginsADTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K

0

2. ADTX Health Analysis

2.1 Basic Checks

  • ADTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ADTX has more shares outstanding
  • Compared to 5 years ago, ADTX has more shares outstanding
  • The debt/assets ratio for ADTX has been reduced compared to a year ago.
ADTX Yearly Shares OutstandingADTX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20K 40K 60K 80K 100K
ADTX Yearly Total Debt VS Total AssetsADTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of -32.13, we must say that ADTX is in the distress zone and has some risk of bankruptcy.
  • ADTX's Altman-Z score of -32.13 is on the low side compared to the rest of the industry. ADTX is outperformed by 89.17% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -32.13
ROIC/WACCN/A
WACC9.04%
ADTX Yearly LT Debt VS Equity VS FCFADTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

  • A Current Ratio of 0.02 indicates that ADTX may have some problems paying its short term obligations.
  • ADTX's Current ratio of 0.02 is on the low side compared to the rest of the industry. ADTX is outperformed by 95.55% of its industry peers.
  • A Quick Ratio of 0.02 indicates that ADTX may have some problems paying its short term obligations.
  • The Quick ratio of ADTX (0.02) is worse than 95.55% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
ADTX Yearly Current Assets VS Current LiabilitesADTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

1

3. ADTX Growth Analysis

3.1 Past

  • ADTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -43.91%.
  • Looking at the last year, ADTX shows a very negative growth in Revenue. The Revenue has decreased by -97.17% in the last year.
  • ADTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.80% yearly.
EPS 1Y (TTM)-43.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.29%
Revenue 1Y (TTM)-97.17%
Revenue growth 3Y6.8%
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2096.63%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1584.79%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ADTX Yearly Revenue VS EstimatesADTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 5M 10M 15M 20M
ADTX Yearly EPS VS EstimatesADTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -5B -10B -15B -20B -25B

0

4. ADTX Valuation Analysis

4.1 Price/Earnings Ratio

  • ADTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ADTX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ADTX Price Earnings VS Forward Price EarningsADTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADTX Per share dataADTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20K -40K -60K -80K -100K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. ADTX Dividend Analysis

5.1 Amount

  • ADTX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ADTX Fundamentals: All Metrics, Ratios and Statistics

ADITXT INC

NASDAQ:ADTX (4/10/2026, 8:05:08 PM)

After market: 0.5015 0 (-0.1%)

0.502

-0.03 (-5.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-31
Earnings (Next)05-13
Inst Owners0.5%
Inst Owner Change22.72%
Ins Owners2.16%
Ins Owner Change0%
Market Cap451.80K
Revenue(TTM)6.00K
Net Income(TTM)-42.24M
Analysts80
Price TargetN/A
Short Float %N/A
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 75.3
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-101947.18
EYN/A
EPS(NY)-252.96
Fwd EYN/A
FCF(TTM)-25.1
FCFYN/A
OCF(TTM)-25.1
OCFYN/A
SpS0.01
BVpS-8.59
TBVpS-8.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -357.97%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-152.11%
ROA(5y)-160.9%
ROE(3y)-396.44%
ROE(5y)-345.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z -32.13
F-Score2
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.29%
EPS Next Y-2096.63%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-97.17%
Revenue growth 3Y6.8%
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year1584.79%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.74%
OCF growth 3YN/A
OCF growth 5YN/A

ADITXT INC / ADTX Fundamental Analysis FAQ

What is the fundamental rating for ADTX stock?

ChartMill assigns a fundamental rating of 0 / 10 to ADTX.


Can you provide the valuation status for ADITXT INC?

ChartMill assigns a valuation rating of 0 / 10 to ADITXT INC (ADTX). This can be considered as Overvalued.


What is the profitability of ADTX stock?

ADITXT INC (ADTX) has a profitability rating of 0 / 10.


Can you provide the financial health for ADTX stock?

The financial health rating of ADITXT INC (ADTX) is 0 / 10.